Evidence map›Paper›PMID 8855295›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1996

Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages.

L Proudfoot, A V Nikolaev, G J Feng, W Q Wei, M A Ferguson, J S Brimacombe, F Y Liew

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 187 citations in OpenAlex.

  1. Frontiers in immunology · 2026
    Review
  2. Review
  3. Frontiers in immunology · 2024
    Article
  4. Review
  5. Phenotypical Differences betweenPathogens (Basel, Switzerland) · 2023
    Article
  6. Chromatin-Remodeling Factor BRG1 Is a Negative Modulator ofFrontiers in cellular and infection microbiology · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Frontiers in microbiology · 2018
    Review
  11. Article
  12. Article
  13. Article
  14. The genetics of Leishmania virulence.Medical microbiology and immunology · 2015
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

L ProudfootDepartment of Immunology, University of Glasgow, Western Infirmary, Scotland.
A V Nikolaev
G J Feng
W Q Wei
M A Ferguson
J S Brimacombe
F Y Liew
Western Infirmary · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Lipophosphoglycan (LPG) glycoconjugates from promastigotes of Leishmania were not able to induce the expression of the cytokine-inducible nitric oxide synthase (iNOS) by the murine macrophage cell line, J774. However, they synergize with interferon gamma to stimulate the macrophages to express high levels of iNOS. This synergistic effect was critically time-dependent. Preincubation of J774 cells with the LPG glycans 4-18 h before stimulation with interferon gamma resulted in a significant reduction in the expression of iNOS mRNA and of NO synthesis, compared with cells preincubated with culture medium alone. The regulatory effect on the induction of iNOS by LPG is located in the LPG phosphoglycan disaccharide backbone. Synthetic fragments of this backbone had a similar regulatory effect on NO synthesis. Further, the production of NO by activated macrophages in the present system was correlated directly with the leishmanicidal capacity of the cells. These data therefore demonstrate that LPG glycoconjugates have a profound effect on the survival of Leishmania parasites through their ability to regulate the expression of iNOS by macrophages.

Indexed as

AnimalsCarbohydrate SequenceCytotoxicity, ImmunologicGene Expression Regulation, EnzymologicGlycosphingolipidsImmunity, CellularInterferon-gammaLeishmania majorMacrophagesMiceMolecular Sequence DataNitric Oxide SynthaseRecombinant ProteinsRNA, MessengerGlycosphingolipidsInterferon-gammalipophosphonoglycanNitric Oxide SynthaseRecombinant ProteinsRNA, Messenger

Identifiers

PMID8855295
PMCPMC38270
OpenAlexW2160272784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.